The Canadian Journal of Cardiology
-
Publication Venue For
- Removing the "Man" in "Mannikin": The Importance of Sociodemographic Diversity in Resuscitation Training.. 38:1907-1910. 2022
- Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis. 32:S8. 2016
- Rapidly progressing mycotic aortic aneurysm masquerading as acute coronary syndrome.. 29:1742.e17-1742.e20. 2013
- 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy. 28:S378-S378. 2012
- Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.. 23:1073-1079. 2007
- Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods. 23:59C-59C. 2007
- Valve surgery in octogenarians: in-hospital and long-term outcomes.. 23:223-227. 2007
- Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.. 22:511-515. 2006
- N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.. 22:393-397. 2006
- Pulmonary edema post-cardioversion: a potential calcium signalling problem.. 22:259-262. 2006
- Supervised exercise training improves aerobic capacity and muscle strength in older women with heart failure.. 21:1277-1280. 2005
- The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.. 21:165-171. 2005
- A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.. 20:1343-1349. 2004
- Bridging American-Canadian health care outcome differences: is there really a gap?. 20:1341-1342. 2004
- The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group.. 20:1075-1079. 2004
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).. 20:977-1025. 2004
- Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.. 20:760-766. 2004
- Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.. 20:773-778. 2004
- Stretching for prediction: the case for brain natriuretic peptide.. 20:684-685. 2004
- Interinstitutional variation in the use of abciximab for percutaneous coronary intervention.. 20:405-410. 2004
- Connecting the pieces of the cardiovascular care puzzle in Canada.. 19:1114-1115. 2003
- The everlasting effect of primary percutaneous coronary intervention--even after transport?. 19:1119-1122. 2003
- Do cardiac troponins provide prognostic insight in hemodialysis patients?. 19:907-911. 2003
- Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.. 19:257-263. 2003
- Cost effectiveness in Canada of eptifibatide treatment for acute coronary syndrome patients using PURSUIT subgroup analysis.. 19:161-166. 2003
- Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use.. 18:941-944. 2002
- Metastatic intracardiac tumour from liposarcoma.. 18:777-778. 2002
- Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity.. 18:430-432. 2002
- Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States. 16:1231-1239. 2000
- Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.. 16:1231-1239. 2000
- POEMS syndrome: a clue to understanding primary pulmonary hypertension? A review of current insights into the pathogenesis of primary pulmonary hypertension.. 16:975-981. 2000
- Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?. 16:1007-1012. 2000
- Adverse effects of corticosteroids on the cardiovascular system.. 16:505-511. 2000
- Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. 15:1095-1102. 1999
- Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).. 15:1095-1102. 1999
- Transmyocardial laser revascularization: experimental and clinical results.. 15:797-806. 1999
- The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era.. 14:1057-1066. 1998
- When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial--an overview. Efficacy and Safety of Subcutaneous in non-Q Wave Coronary Events.. 14 Suppl E:24E-27E. 1998
- Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.. 13:909-913. 1997
- Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact.. 13:507-516. 1997
- Novel methodology for echocardiographic quantification of cardiac shape.. 13:153-159. 1997
- Unstable angina--report from a Canadian expert roundtable.. 12:1279-1292. 1996
- Evolution of the CCU from rhythm, function and protection to reperfusion and beyond: a personal journey and perspective.. 12:909-913. 1996
- Collaborative cardiovascular clinical research in Canada: coming of age.. 11:645-647. 1995
- Molecular biology of angiotensin II biosynthesis and receptors.. 11 Suppl F:21F-26F. 1995
- From thrombolytic megatrials to clinical policy-making: facing the facts.. 11:472-476. 1995
- Lipoprotein(a) and apolipoproteins B and A-I after acute myocardial infarction.. 11:206-210. 1995
- Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients.. 11:117-122. 1995
- Chronic false aneurysms of the left ventricle: management revisited.. 10:927-931. 1994
- Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.. 10:897-904. 1994
- Canadian Consensus Conference on Coronary Thrombolysis--1994 update.. 10:517-521. 1994
- Structural remodelling in heart failure: gelatinase induction.. 10:214-220. 1994
- Analysis of responses to big endothelin in the hindquarters vascular bed of the cat.. 8:954-960. 1992
- Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarction.. 8:709-715. 1992
- Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.. 7:117-124. 1991
- The effects of atrial fibrillation on regional blood flow in the awake dog.. 3:240-245. 1987
- Myocardial bridges: effect of propranolol on systolic compression.. 2:218-221. 1986
- Does Atrial Fibrillation Affect Outcomes in Patients Admitted With Acute Heart Failure? Insights From the Ascend-Hf Trial 2013
- 650 Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From ASCEND-HF 2012
- 819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial 2012
- 508 Acute heart failure: Canadian perspectives from an RCT and a registry 2011
- BINDING OF ANTI-GRP78 AUTOANTIBODIES TO CELL SURFACE GRP78 INCREASES TISSUE FACTOR PROCOAGULANT ACTIVITY VIA THE RELEASE OF CALCIUM FROM ENDOPLASMIC RETICULUM STORES 2010
- Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 ARG/GLY receptor polymorphism 2007
- [Canadian Consensus Conference on Coronary Thrombolysis--current aspects]. 1995
- Canadian Task Force for Cardiovascular Science. A Joint Initiative of the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Society. 1993
- Important patient subgroups in thrombolytic therapy. 1993
- New dose regimens for coronary thrombolysis. 1993
- Postcoronary thrombolysis management. 1993